Company: INGN
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0000950170-25-045737
Chunk: 60

Company: Inogen Inc
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 60
---
 OncoSec Medical, Inc., a biotechnology company, and served on its Board of Directors from 2020 to 2023. In his previous roles, Mr. Smith served as Executive Vice President of Development at Gel-e, Inc., as Chief Commercial Officer at Sensium Healthcare, as Global Vice President of Sales & Marketing at Teleflex, and served in various sales and marketing roles in medical device companies. Mr. Smith holds an MBA in Global Management from the University of Phoenix and a B.S. in Marketing from the University of Kentucky.

Michael Bourquehas served as our Executive Vice President, Chief Financial Officer and Corporate Treasurer since March 2024. Most recently, Mr. Bourque served as Chief Financial Officer and Treasurer of Chase Corporation, a manufacturer of industrial coatings and tapes for high-reliability applications, from February 2021 to February 2024. He also served as Chief Financial Officer of Keystone Dental Inc. from April 2019 to September 2020. Prior to that, Mr. Bourque served Chief Financial Officerfrom 2017 to 2018 and other senior finance leadership positions from 2014 to 2017 of Analogic Corporation, a corporation specialized in healthcare technology and aviation security industries, and as Vice President of Finance for Axcelis Technologies. Mr. Bourque received a B.S. in Accounting from Bentley University and is a Certified Public Accountant.

Kevin P. Smithhas served as our Executive Vice President, General Counsel, Secretary and Business Development since July 2024. Most recently, Mr. Smith served as General Counsel and Executive Vice President, Business Development of Sirtex Medical, a medical device company, from October 2018 to June 2024. In his prior roles, Mr. Smith served as Vice President and Associate General Counsel at Flexion Therapeutics from 2017 to 2018, as General Counsel for the Danaher Life Sciences Platform from 2012 to 2017, and in several senior legal leadership positions within Novartis Pharmaceuticals in Switzerland and Massachusetts from 2005 to 2012. Before moving in-house, Mr. Smith worked for multinational law firms in London, Silicon Valley, and New York. Mr. Smith earned his B.S. in Mechanical Engineering from Rensselaer Polytechnic Institute and his J.D. from Albany Law School.

Gregoire Ramadehas served as our Chief Commercial Officer since January 2024 and served as our Senior Vice President of International Sales from November 2023 to January 2024